Form 4: Modular Medical Executives and Entities Report Acquisition of Shares and Warrants
SEC Form 4
Multiple entities and executives, including Manchester Management and James E. Besser, reported acquiring Modular Medical, Inc. common stock and warrants at a price of $1.92 per share.
Summary
- Manchester Explorer, L.P. acquired 260,416 units, each consisting of two shares of common stock and one warrant, at $1.92 per share on March 20, 2025.
- James E. Besser acquired 78,125 units, each consisting of two shares of common stock and one warrant, at $1.92 per share on March 20, 2025.
- The warrants acquired by Manchester Explorer, L.P. and James E. Besser are anticipated to become exercisable on or about March 25, 2025, with an exercise price of $1.12.
- The filing also details existing direct and indirect ownership of common stock and options by various entities and individuals, including Manchester Management, Manchester PR, James E. Besser, and Morgan C. Frank.
- Morgan C. Frank directly owns 206,226 shares of common stock.
- The filing includes details of options to purchase common stock held by Morgan C. Frank with various exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisitions by insiders suggest confidence, but the filing itself is simply a report of transactions.
Positives
- The acquisitions by Manchester Explorer, L.P. and James E. Besser at $1.92 per share could be seen as a positive signal of confidence in Modular Medical, Inc.
Future Outlook
The document does not contain explicit forward-looking statements beyond the anticipated exercisability of the warrants on or about March 25, 2025.
Industry Context
This filing reflects insider transactions, which are closely monitored by investors for signals about management's confidence in the company's prospects. The acquisition of shares and warrants by multiple entities associated with management could be interpreted as a positive sign.
Stakeholder Impact
- The reported transactions may influence investor sentiment regarding Modular Medical, Inc.
Key Dates
| Date | Description |
|---|---|
| 12/29/2023 | Date of option grant with exercise price of $1.78 and expiration date of 12/29/2033 |
| 12/31/2023 | Verification and validation testing completed for the Registrant's initial pump product. |
| 01/31/2024 | 510(K) premarket submission to the U.S. Food and Drug Administration (FDA) for the Registrant's initial pump product was completed. |
| 03/20/2025 | Date of transaction for acquisition of common stock and warrants by Manchester Explorer, L.P. and James E. Besser. |
| 03/25/2025 | Anticipated date when warrants acquired by Manchester Explorer, L.P. and James E. Besser will become exercisable. |
Keywords
Modular Medical, MODD, Manchester Management, James E. Besser, Morgan C. Frank, ownership, Form 4, acquisition, warrants, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.